Clinical Research Informer

tag inhalers

Grand Rounds July 22, 2022: ACTIV-6: 1-Year Later and Trial Results for Ivermectin-400 and Inhaled Fluticasone (Susanna Naggie, MD, MHS)

Rethinking Clinical Trials

JULY 27, 2022

ACTIV, ACTIV-6, COVID-19, Ivermectin, Inhaled Fluticasone. The post Grand Rounds July 22, 2022: ACTIV-6: 1-Year Later and Trial Results for Ivermectin-400 and Inhaled Fluticasone (Susanna Naggie, MD, MHS) appeared first on Rethinking Clinical Trials. Susanna Naggie, MD, MHS. Professor of Medicine. Vice Dean for Clinical Research.

Trials

Trials Pharmacy Medicine Clinical Trials

BD partners with Biocorp on connected self-injection devices

pharmaphorum

OCTOBER 18, 2022

Medtech giant Beckton Dickinson (BD) has signed a deal with France’s Biocorp to use the latter’s near-field communication (NFC) tags in injectable devices. The Injay tag can confirm a complete injection and transfer that information via an NFC reader to a smartphone or tablet for review by a healthcare professional.

Drug Delivery

Drug Delivery Manufacturing Drugs Marketing

Join 32,000+

Insiders

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

Grand Rounds February 3, 2023: Pragmatic Trials For Children With Congenital Heart Disease – Insights From The NITRIC Trial (Luregn Schlapbach, PhD, FCICM)

Rethinking Clinical Trials

FEBRUARY 13, 2023

All patients could receive inhalation NO during/after surgery if considered indicated by the treatment team. The intervention was applied by perfusionists at a steady concentration from the start until the end of bypass. All other surgical staff were blinded. There was no use of nitric oxide (NO) during CPB controls.

Trials

Trials Clinical Trials Clinical Trials Research

Further insight into breakthroughs in mRNA drug discovery

Drug Discovery World

JULY 25, 2023

We have shown that the excipient does not only work for our SNAP-tag lipid (SNaP) LNP, but also for the commercialised vaccines. The process was developed because for inhalation of mRNA, you need a lot of material, so from the beginning on we were focused on developing a process that would allow us to produce larger quantities of mRNA.

Drugs

Drugs Packaging Packaging Manufacturing

What to expect from PEGS Europe 2023: Day 3

Drug Discovery World

NOVEMBER 13, 2023

Fabian Mohr, PhD, Vice President Research & Development, IBA Lifesciences, on: ‘Developing a robust affinity tag platform using engineered streptavidin’. Stefano Cucuzza, PhD, Postdoctoral Researcher, TRD Biologics & CGT, Novartis Pharma, on: ‘Not the usual suspects: Alternative surfactants for biopharmaceuticals’.

Protein